美国卫生资源和服务管理局 (HRSA) 已批准首批九种药品参与新返利模式的试点项目: 340B 折扣计划——这正是大型制药公司一直以来所呼吁的。去年,多家制药公司提起诉讼,认为符合 340B 资格的医院(服务于无保险和低收入患者)应该在支付全价后申请现金返还,而不是预先获得大幅折扣。强生、礼来和BMS声称该计划存在大量滥用现象,并指控大型医院系统利用折扣抬高无保险患者和保险公司的药品价格。尽管强生...
Source Link美国卫生资源和服务管理局 (HRSA) 已批准首批九种药品参与新返利模式的试点项目: 340B 折扣计划——这正是大型制药公司一直以来所呼吁的。去年,多家制药公司提起诉讼,认为符合 340B 资格的医院(服务于无保险和低收入患者)应该在支付全价后申请现金返还,而不是预先获得大幅折扣。强生、礼来和BMS声称该计划存在大量滥用现象,并指控大型医院系统利用折扣抬高无保险患者和保险公司的药品价格。尽管强生...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.